SANA — Sana Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00- $853.97m
- $715.59m
Annual cashflow statement for Sana Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -356 | -269 | -283 | -267 | -244 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 84 | -43.7 | -13.5 | 27.4 | 97.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 9.8 | 7.54 | 18.6 | -1.19 | -10.1 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -251 | -290 | -254 | -223 | -144 |
| Capital Expenditures | -29.9 | -20.9 | -20 | -33.4 | -0.938 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -216 | 231 | 192 | 50.9 | -39.3 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -246 | 211 | 172 | 17.5 | -40.2 |
| Financing Cash Flow Items | — | — | — | 7.74 | -0.347 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 632 | 4.91 | 31.6 | 200 | 129 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 135 | -74.6 | -49.9 | -5.95 | -55.3 |